Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2022 Jan 25;16(2):486–487. doi: 10.1007/s12072-022-10301-2

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

George Lau 1,2,✉, Ming-Lung Yu 3,✉, Grace Wong 4, Alexander Thompson 5, Hasmik Ghazinian 6, Jin-Lin Hou 7, Teerha Piratvisuth 8, Ji-Dong Jia 9, Masashi Mizokami 10, Gregory Cheng 2,11, Guo-Feng Chen 12, Zhen-Wen Liu 13, Oidov Baatarkhuu 14, Ann Lii Cheng 15, Woon Leung Ng 16, Patrick Lau 1, Tony Mok 17, Jer-Ming Chang 18, Saeed Hamid 19, A Kadir Dokmeci 20, Rino A Gani 21, Diana A Payawal 22, Pierce Chow 23, Joong-Won Park 24, Simone I Strasser 25, Rosmawaiti Mohamed 26, Khin Maung Win 27, Tawesak Tanwandee 28, Shiv Kumar Sarin 29, Masao Omata 30,31
PMCID: PMC9119228  PMID: 35076895

Correction to: Hepatology International (2021) 15:1031–1048 https://doi.org/10.1007/s12072-021-10239-x

Unfortunately, the first and last name of the Co-author, Tawesak Tanwandee has been interchanged in the original publication of the article. The correct first name should read as “Tawesak” and the last name should read as “Tanwandee” respectively.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

George Lau, Email: gkklau@hnhmgl.com, Email: gkklau@netvigator.com.

Ming-Lung Yu, Email: fish6069@gmail.com.

Articles from Hepatology International are provided here courtesy of Nature Publishing Group

RESOURCES